An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
48mon MSN
The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...
The Food and Drug Administration Wednesday abruptly and unexpectedly cancelled a planned March 13 vaccine advisory committee ...
The U.S. Food and Drug Administration confirmed on Thursday that a meeting of a committee which advises the regulator on ...
It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top ...
The Food and Drug Administration abruptly canceled a critical meeting of the Vaccines and Related Biological Products ...
The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official ...
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in ...
The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.
The cancellation of this meeting raises concerns that other federal health advisory panels may also be in jeopardy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results